Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells. Issue 1 (1st January 2020)
- Record Type:
- Journal Article
- Title:
- Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells. Issue 1 (1st January 2020)
- Main Title:
- Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells
- Authors:
- Oh, Seung-ick
Jeong, Hyesun
Park, Hang-soo
Choi, Kyung-Ah
Hwang, Insik
Lee, Jiyun
Cho, Jeonghee
Hong, Sunghoi - Abstract:
- Abstract: Cancer stem cells (CSCs) have been implicated in the growth and progression of several types of human cancer. The technology to derive and establish CSCs in vitro could be a critical tool for understanding cancer and developing new therapeutic targets. In this study, we derived expandable CD15 + induced CSCs (iCSCs) from immortalised 293FT human epithelial cells by co-culture with human bone marrow-derived mesenchymal stem cells (BM-MSCs) as feeder cells in vitro . The iCSCs converted through an epithelial-mesenchymal transition program acquired mesenchymal traits, the expression of stem cell markers, and epigenetic changes. Moreover, the iCSCs not only efficiently formed tumorspheres in vitro but also initiated tumours in immunocompromised mice injected with only 10 of the iCSCs. Furthermore, we showed that the expression of the chemokine CXCL12 and its receptor CXCR4 by the iCSCs resulted in the activation of the Fut4 gene through CXCR4/ERK/ELK-1-signalling pathways and the maintenance of the iCSCs in the undifferentiated state through CXCR4/AKT/STAT3-signalling. These findings suggest that immortalised 293FT cells may acquire potential oncogenicity through molecular and cellular alteration processes in microenvironments using BM-MSCs, and could represent a valuable in vitro model as a cancer stem cell surrogate for studying the pathophysiological properties of CSCs.
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 48:Issue 1(2020)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 48:Issue 1(2020)
- Issue Display:
- Volume 48, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 48
- Issue:
- 1
- Issue Sort Value:
- 2020-0048-0001-0000
- Page Start:
- 1303
- Page End:
- 1313
- Publication Date:
- 2020-01-01
- Subjects:
- iCSCs -- BM-MSC -- 293FT -- CXCR4/CXCL12 -- ERK/ELK1 -- AKT/STAT3
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2020.1841783 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25401.xml